Abstract
Autoimmune myelofibrosis (AIMF) is a rare entity of steroid-responsive bone marrow fibrosis that accompanies a variety of autoimmune diseases, particularly systemic lupus erythematosus (SLE). Rarely it may occur in patients with autoimmune markers but no definable autoimmune disease (Primary-AIMF). We report the cases of two young women with SLE-associated AIMF (SLE-AIMF). The first patient was a young woman who had pancytopenia, massive splenomegaly and reticulin fibrosis in the marrow biopsy. The pancytopenia and splenomegaly resolved completely within weeks of treatment with corticosteroids. Repeat marrow biopsy showed marked regression of marrow fibrosis. The second patient was a young woman with fever, anasarca, bicytopenia and reticulin fibrosis in the marrow biopsy. Steroid therapy resulted in rapid clinical improvement and resolution of pancytopenia. A review of the literature revealed a total of 30 patients with SLE-AIMF reported to-date. Patients with SLE-AIMF are young women with SLE and blood cytopenia who are found to have increased bone marrow reticulin on marrow biopsy. Steroid therapy results in rapid hematological recovery and regression of marrow fibrosis. Whether AIMF is one of several hematological complications of SLE, or represents a unique and distinct subset of patients with SLE in not clear. Prospective studies with longer follow-up are needed to better define the prevalence and clinical spectrum of SLE-AIMF.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
McCarthy DM (1985) Fibrosis of the bone marrow: content and causes. Br J Haematol 59:1–7
Kuter DJ, Bain B, Mufti G, Bagg A, Hasserjian RP (2007) Bone marrow fibrosis: pathophysiology and clinical significance of increased bone marrow stromal fibres. Br J Haematol 139:351–362
Paquette RL, Meshkinpour A, Rosen PJ (1994) Autoimmune myelofibrosis. A steroid-responsive cause of bone marrow fibrosis associated with systemic lupus erythematosus. Medicine (Baltim) 73:145–152
Bass RD, Pullarkat V, Feinstein DI, Kaul A, Winberg CD, Brynes RK (2001) Pathology of autoimmune myelofibrosis. A report of three cases and a review of the literature. Am J Clin Pathol 116:211–216
Pullarkat V, Bass RD, Gong JZ, Feinstein D, Brynes RK (2003) Primary autoimmune myelofibrosis: definition of a distinct clinicopathologic syndrome. Am J Hematol 72:219–222
Rizzi R, Pastore D, Liso A, Liuzzi GM, Dalena AM, Specchia G, Ricco R, Liso V (2004) Autoimmune myelofibrosis: report of three cases and review of the literature. Leuk Lymphoma 45:561–566
Giannoutsos I, Heaton D (2006) Autoimmune marrow fibrosis with cytopenias responsive to methotrexate. Leuk Lymphoma 47:1674–1676
Santos FPS, Konoplev SN, Lu H, Verstovsek S (2010) Primary autoimmune myelofibrosis in a 36-year-old patient presenting with isolated extreme anemia. Leuk Res 34:e35–e37
Petri M, Orbai A-M, Alarcon GS et al (2012) Derivation of validation of systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64:2677–2686
Hahn BH (2012) Systemic lupus erythematosus. In: Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J (eds) Harrison’s principles of internal medicine. McGraw Hill, New York, p 2731
Daly HM, Scott GL (1983) Myelofibrosis as a cause of pancytopenia in systemic lupus erythematosus. J Clin Pathol 36:1219–1222
Wanitpongpun C, Teawtrakul N, Mahakkanukrauh A, Siritunyaporn S, Sirijerachai C, Chansung K (2012) Bone marrow abnormalities in systemic lupus erythematosus with blood cytopenia. Clin Exp Rheumatol 30:825–829
Pereira RMR, Velloso ERP, Menezes Y, Gualandro S, Vassalo J, Yoshinari NH (1998) Bone marrow findings in systemic lupus erythematosus patients with peripheral cytopenias. Clin Rheumatol 17:219–222
Voulgarelis M, Giannouli S, Tasidou A, Anagnostou D, Ziakas PD, Tzioufas AG (2006) Bone marrow histological findings in systemic lupus erythematosus with hematologic abnormalities: a clinicopathological study. Am J Hematol 81:590–597
Feng C-S, Ng MHL, Szeto RSC, Li EK (2006) Bone marrow findings in lupus patients with pancytopenia. Pathology 23:5–7
Kreipe H, Busche G, Bock O, Hussein K (2012) Myelofibrosis: molecular and cell biological aspects. Fibrogenesis Tissue Repair 5(Suppl 1):S21
Zeisberg M, Kalluri R (2013) Cellular mechanisms of tissue fibrosis. 1. Common and organ-specific mechanisms with tissue fibrosis. Am J Physiol Cell Physiol 304:C216–C225
Cappio FC, Vigliani R, Novarino A, Camussi G, Campana D, Gavosto F (1981) Idiopathic myelosclerosis: a possible role for immune-complexes in the pathogenesis of bone marrow fibrosis. Br J Haematol 49:17–21
Barcellini W, Lurlo A, Radice T et al (2013) Increased prevalence of autoimmune phenomena in myelofibrosis: relationship with clinical and morphological characteristics, and with immunoregulatory cytokine patterns. Leuk Res 37:1509–1515
Harrison JS, Corcoran KE, Joshi D, Sophacleus C, Rameshwar P (2006) Peripheral monocytes and CD4 + cells are potential sources for increased circulating levels of TGF-β and substance P in autoimmune myelofibrosis. Am J Hematol 81:51–58
Hold GL, Untiveros P, Saunders K, El-Omar EM (2009) Role of host genetics in fibrosis. Fibrogenesis Tissue Repair 2:6–17
Conflict of interest
The authors declare that they have no conflict of interest to declare.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Koduri, P.R., Parvez, M., Kaza, S. et al. Autoimmune Myelofibrosis in Systemic Lupus Erythematosus Report of Two Cases and Review of the Literature. Indian J Hematol Blood Transfus 32, 368–373 (2016). https://doi.org/10.1007/s12288-015-0516-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12288-015-0516-3